SEC Form 4 · accession 0001127602-16-043390
INSULET CORP · PODD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J Levangie
Officer — President, Drug Delivery
Period of report
Feb 23, 2016
Accepted (ET)
Feb 25, 2016 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001145197
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 23, 2016 | A | 6,813 | $0.00 | A | 17,476 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The 6,813 performance share units were granted on April 1, 2015, and the Compensation Committee of the Board of Directors determined on February 23, 2016 that the performance share units were earned based on the performance of the Company. The full award remains subject to time-based vesting in accordance with the following schedule: one-third of the performance share units vest on April 1, 2016, one-third of the performance share units vest on April 1, 2017 and one-third of the performance share units vest on April 1, 2018. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- F2Includes 1,000 restricted stock units granted on June 3, 2013 which vest on April 30, 2016; and 2,000 restricted stock units granted on June 2, 2014, which vest 50% of the total units on April 30, 2016 and 50% of the total units on April 30, 2017, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.